Explore studies, research summaries, frequently asked questions, glossary terms, articles, and comparison guides.
Published in Cell Metabolism (2015), this landmark study by Dr. Changhan David Lee and colleagues at USC describes the discovery of MOTS-c — a novel peptide encoded in the mitochondrial genome's 12S rRNA gene. The study demonstrated that MOTS-c targets the folate cycle and de novo purine biosynthesis pathway, activating AMPK signaling to regulate insulin sensitivity and metabolic homeostasis. Treatment with MOTS-c prevented age-dependent and high-fat-diet-induced insulin resistance in mice, establishing it as a key mitochondrial-derived signaling molecule.
This groundbreaking research revealed that MOTS-c translocates from the cytoplasm to the nucleus during metabolic stress. Once in the nucleus, MOTS-c directly interacts with DNA to regulate gene expression involved in antioxidant response and glucose metabolism. This nuclear translocation represents a novel mechanism of mito-nuclear communication, where a mitochondrial-encoded peptide can directly influence nuclear gene expression — challenging the traditional view of mitochondria as passive organelles.
MOTS-c (Mitochondrial Open Reading Frame of the Twelve S rRNA type-c) is a 16-amino-acid peptide encoded within the mitochondrial genome. Unlike the vast majority of proteins that are encoded by nuclear DNA, MOTS-c is produced directly from mitochondrial DNA. Discovered in 2015 by researchers at the University of Southern California, MOTS-c has emerged as a key player in metabolic regulation, exercise biology, stress response, and aging research. It activates AMPK (AMP-activated protein kinase), a master energy sensor, and has shown the remarkable ability to translocate to the nucleus under metabolic stress to directly regulate gene expression.
Mitochondria are double-membrane organelles found in nearly every eukaryotic cell. Often called the 'powerhouses of the cell,' mitochondria produce approximately 90% of the body's adenosine triphosphate (ATP) through oxidative phosphorylation. Beyond energy production, mitochondria play critical roles in calcium signaling, apoptosis (programmed cell death), reactive oxygen species (ROS) generation, and cellular metabolism. Uniquely, mitochondria possess their own circular DNA genome (mtDNA) inherited maternally, which encodes 13 proteins, 22 tRNAs, and 2 rRNAs — plus newly discovered mitochondrial-derived peptides like MOTS-c and Humanin.
ATP (adenosine triphosphate) production occurs primarily through oxidative phosphorylation in the mitochondria. The process begins when nutrients (glucose, fatty acids) are broken down through glycolysis and the citric acid cycle, generating electron carriers (NADH, FADH2). These carriers donate electrons to the electron transport chain (ETC) — a series of protein complexes embedded in the inner mitochondrial membrane. As electrons flow through Complexes I-IV, protons are pumped across the membrane, creating an electrochemical gradient. ATP synthase (Complex V) harnesses this proton gradient to synthesize ATP from ADP. A single glucose molecule can yield approximately 30-36 ATP molecules through this remarkably efficient process.
The primary energy currency of biological cells. ATP stores chemical energy in its phosphoanhydride bonds. When ATP is hydrolyzed to ADP (adenosine diphosphate) and inorganic phosphate, energy is released to power cellular processes including muscle contraction, nerve impulse propagation, protein synthesis, and active transport.
A highly conserved serine/threonine kinase that serves as a master regulator of cellular energy homeostasis. AMPK is activated when cellular energy is depleted (high AMP/ATP ratio) and responds by switching on catabolic pathways that generate ATP (fatty acid oxidation, glucose uptake) while switching off energy-consuming anabolic processes. MOTS-c activates AMPK signaling, which is central to its metabolic regulatory effects.
A class of bioactive peptides encoded within the mitochondrial genome. MDPs are translated from small open reading frames (sORFs) within mitochondrial DNA. Known MDPs include MOTS-c, Humanin, and the SHLPs (Small Humanin-Like Peptides). These peptides function as retrograde signaling molecules, communicating mitochondrial status to the rest of the cell and influencing metabolism, stress response, and cell survival.
Research has demonstrated a striking relationship between physical exercise and MOTS-c. Circulating MOTS-c levels increase significantly following exercise in humans. Studies in aged mouse models show that MOTS-c treatment can improve physical capacity, suggesting it may mediate some of the metabolic benefits of exercise. This has led researchers to investigate MOTS-c as a potential 'exercise mimetic' — a molecule that could reproduce certain benefits of physical activity. While exercise remains irreplaceable, understanding how MOTS-c mediates its effects could open new therapeutic avenues for individuals unable to exercise due to age, injury, or disease.
Nicotinamide adenine dinucleotide (NAD+) is an essential coenzyme for mitochondrial energy metabolism, serving as a critical electron carrier in the electron transport chain. NAD+ levels decline significantly with age — a decline that correlates with mitochondrial dysfunction, metabolic disease, and the hallmarks of aging. Research into NAD+ precursors (NMN, NR) has shown promise in restoring mitochondrial function and extending healthspan in animal models. The intersection of NAD+ biology and mitochondrial-derived peptide signaling (including MOTS-c) represents a frontier of longevity research, as both pathways converge on AMPK activation and metabolic regulation.
MOTS-c and SS-31 (Elamipretide) both target mitochondrial function but through fundamentally different mechanisms. MOTS-c is an endogenous mitochondrial-derived peptide that activates AMPK signaling, regulates glucose metabolism, and can translocate to the nucleus to modulate gene expression. SS-31, a synthetic tetrapeptide, works by binding to cardiolipin in the inner mitochondrial membrane, stabilizing the electron transport chain and reducing oxidative damage. SS-31 is currently in clinical trials for conditions including heart failure (Barth syndrome) and mitochondrial myopathies. While MOTS-c represents endogenous mitochondrial signaling, SS-31 represents targeted therapeutic engineering — both advancing our understanding of mitochondrial medicine from different angles.
The metabolic pathway in which mitochondria use enzyme complexes in the inner membrane to generate ATP from the energy released by electron transfer. It is the final stage of cellular respiration and produces the majority of ATP in aerobic organisms. The process couples electron transport through Complexes I-IV with proton pumping to create a chemiosmotic gradient that drives ATP synthase.
Bioregulators are short peptides (typically 2-4 amino acids) developed through decades of research by Professor Vladimir Khavinson at the St. Petersburg Institute of Bioregulation and Gerontology. These peptides are designed to target specific tissues and organs, potentially restoring gene expression patterns associated with youthful function. Research has explored bioregulators for the thymus (Thymalin), pineal gland (Epithalamin/Epithalon), and various organ systems. While the field remains in early stages with much research needed, the concept of tissue-specific peptide bioregulation represents an intriguing approach to addressing age-related decline.
GHK-Cu (glycyl-L-histidyl-L-lysine copper complex) is a naturally occurring tripeptide found in human plasma, saliva, and urine. Research has demonstrated its involvement in wound healing, tissue remodeling, collagen synthesis, and gene expression modulation. Studies suggest GHK-Cu may influence over 4,000 human genes — approximately 6% of the genome. Its effects span anti-inflammatory activity, antioxidant protection, stem cell attraction, nerve regeneration, and fibroblast activation. Like MOTS-c, GHK-Cu represents a small peptide with outsized biological influence, though through entirely different mechanisms.
Communication from mitochondria back to the nucleus. Unlike anterograde signaling (nucleus to mitochondria), retrograde signaling allows mitochondria to inform the nucleus about their functional status, triggering adaptive nuclear gene expression changes. MOTS-c nuclear translocation is a dramatic example — the peptide physically moves from mitochondria to the nucleus to directly modify gene expression under metabolic stress.